National Quality Measures Clearinghouse | Aminoglycoside monitoring | Documentation of known adverse drug reactions (ADRs) | Medication orders with error-prone abbreviations | Warfarin management: Australian Council on Healthcare Standards.

Measure Summaries
Australian Council on Healthcare Standards

Aminoglycoside monitoring: percentage of patients with a toxic aminoglycoside concentration whose dosage has been adjusted prior to the next aminoglycoside dose, during the 6 month time period.
National Quality Measures Clearinghouse | Aminoglycoside monitoring: percentage of patients with a toxic aminoglycoside concentration whose dosage has been adjusted prior to the next aminoglycoside dose, during the 6 month time period.

 

Documentation of known adverse drug reactions (ADRs): percentage of patients whose known ADRs are documented on the current medication chart. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Documentation of known adverse drug reactions (ADRs): percentage of patients whose known ADRs are documented on the current medication chart.


Medication orders with error-prone abbreviations: percentage of medication orders that include error-prone abbreviations. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Medication orders with error-prone abbreviations: percentage of medication orders that include error-prone abbreviations.


Warfarin management: percentage of non same-day separations receiving warfarin as an inpatient who experience abnormal bleeding, during the 6 month time period. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Warfarin management: percentage of non same-day separations receiving warfarin as an inpatient who experience abnormal bleeding, during the 6 month time period.


Warfarin management: percentage of non same-day separations receiving warfarin as an inpatient with an international normalized ratio (INR) reading greater than 5, during the 6 month time period. This updates a previously published measure summary.
National Quality Measures Clearinghouse | Warfarin management: percentage of non same-day separations receiving warfarin as an inpatient with an international normalized ratio (INR) reading greater than 5, during the 6 month time period.


Warfarin management: percentage of patients discharged on warfarin who receive written drug information prior to discharge, during the 6 month time period.
National Quality Measures Clearinghouse | Warfarin management: percentage of patients discharged on warfarin who receive written drug information prior to discharge, during the 6 month time period.


Warfarin management: percentage of patients on warfarin with an international normalized ratio (INR) result of 4 or above whose dosage has been adjusted or reviewed prior to the next warfarin dose, during the 6 month time period.

National Quality Measures Clearinghouse | Warfarin management: percentage of patients on warfarin with an international normalized ratio (INR) result of 4 or above whose dosage has been adjusted or reviewed prior to the next warfarin dose, during the 6 month time period.

Warfarin management: percentage of patients prescribed hospital-initiated warfarin whose starting doses are consistent with a hospital-approved protocol, during the 6 month time period.
National Quality Measures Clearinghouse Warfarin management: percentage of patients prescribed hospital-initiated warfarin whose starting doses are consistent with a hospital-approved protocol, during the 6 month time period.